Design, Synthesis, Structural Characterization, and Enzyme-Kinetic Evaluation of Bis(heteroarylacetamide) Derivatives as Potential Human Thymidylate Synthase Inhibitors

Authors

  • Ihab Abbas Taher Department of Chemistry, College of Science, Mustansiriyah University, Baghdad, Iraq
  • Firyal Weli Askar Department of Chemistry, College of Science, Mustansiriyah University, Baghdad, Iraq
  • Fatin Fadhel Al-Kazzaz Department of Chemistry, College of Science, Mustansiriyah University, Baghdad, Iraq

Keywords:

Thymidylate synthase, bis(heteroaryl acetamide) derivatives, enzyme inhibition, inhibition kinetics, molecular docking, anticancer agents

Abstract

A new series of bis(heteroaryl acetamide) derivatives was synthesized and evaluated as potential human thymidylate synthase (TS) inhibitors. Structural characterization by FTIR, ¹H NMR, and ¹³C NMR confirmed the formation of the target compounds. All derivatives inhibited human TS in the micromolar range, with I2 showing the highest activity (IC50 = 15.65 µM), slightly superior to 5-fluorouracil (5-FU) (IC50 = 16.01 µM), while I3 and I4 showed comparable potencies (IC50 = 16.75 and 17.20 µM, respectively). Molecular docking against human TS (PDB ID: 1HVY) supported the experimental findings, with docking scores of −9.1 to −9.2 kcal/mol for the synthesized compounds versus −7.45 kcal/mol for 5-FU. Kinetic analysis revealed distinct apparent inhibition behaviors: I1 showed mixed inhibition; I2 was noncompetitive; I3 was uncompetitive and exhibited the lowest Ki when mTHF was varied; whereas I4 displayed substrate-dependent inhibition, being uncompetitive with respect to dUMP and noncompetitive with respect to mTHF. These findings identify this series as a promising source of structurally novel TS-directed inhibitors.

Downloads

Published

2026-11-15

Issue

Section

Articles

How to Cite

1.
Ihab Abbas Taher, Firyal Weli Askar, Fatin Fadhel Al-Kazzaz. Design, Synthesis, Structural Characterization, and Enzyme-Kinetic Evaluation of Bis(heteroarylacetamide) Derivatives as Potential Human Thymidylate Synthase Inhibitors. Sawa Med. J. [Internet]. 2026 Nov. 15 [cited 2026 Nov. 17];2(4):75-100. Available from: https://smj.sawauniversity.edu.iq/article/view/858